566 results on '"Drosten, Christian"'
Search Results
2. Author Correction: Immunogenetic-pathogen networks shrink in Tome’s spiny rat, a generalist rodent inhabiting disturbed landscapes
3. Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays
4. An updated framework for SARS-CoV-2 variants reflects the unpredictability of viral evolution
5. SARS-CoV-2 rapid antigen test sensitivity and viral load in newly symptomatic hospital employees in Berlin, Germany, December, 2020 to February, 2022: an observational study
6. Biphasic MERS-CoV Incidence in Nomadic Dromedaries with Putative Transmission to Humans, Kenya, 2022–2023
7. Ineffectiveness of international travel restrictions to contain spread of the SARS-CoV-2 Omicron BA.1 variant: a continent-wide laboratory-based observational study from Africa
8. Immunogenetic-pathogen networks shrink in Tome’s spiny rat, a generalist rodent inhabiting disturbed landscapes
9. SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency
10. Distinct phenotype of SARS-CoV-2 Omicron BA.1 in human primary cells but no increased host range in cell lines of putative mammalian reservoir species
11. A bead-based multiplex assay covering all coronaviruses pathogenic for humans for sensitive and specific surveillance of SARS-CoV-2 humoral immunity
12. Divergent Genotype of Hepatitis A Virus in Alpacas, Bolivia, 2019
13. Characterization of intrinsic and effective fitness changes caused by temporarily fixed mutations in the SARS-CoV-2 spike E484 epitope and identification of an epistatic precondition for the evolution of E484A in variant Omicron
14. Relative vaccine effectiveness of a CoronaVac booster dose in preventing symptomatic SARS-CoV-2 infection among healthcare workers during an Omicron period in Azerbaijan, January–August 2022
15. Primary series and booster COVID-19 vaccine effectiveness in a cohort of healthcare workers in Albania during a BA.1 and BA.2 variant period, January – May 2022
16. Mapping SARS-CoV-2 antigenic relationships and serological responses
17. The effectiveness of primary series CoronaVac vaccine in preventing COVID‐19 illness: A prospective cohort study among healthcare workers in Azerbaijan, May–November 2021
18. Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera
19. Pharmacological inhibition of bromodomain and extra-terminal proteins induces an NRF-2-mediated antiviral state that is subverted by SARS-CoV-2 infection
20. Functional comparisons of the virus sensor RIG-I from humans, the microbat Myotis daubentonii , and the megabat Rousettus aegyptiacus , and their response to SARS-CoV-2 infection
21. Whole genome sequencing reveals insights into hepatitis E virus genome diversity, and virus compartmentalization in chronic hepatitis E
22. Primary series COVID-19 vaccine effectiveness among healthcare workers in Albania, February–December 2021
23. Results of German external quality assessment schemes for SARS-CoV-2 antigen detection
24. Antigenic cartography using variant-specific hamster sera reveals substantial antigenic variation among Omicron subvariants
25. MHC class II genes mediate susceptibility and resistance to coronavirus infections in bats
26. 90K/LGALS3BP expression is upregulated in COVID-19 but may not restrict SARS-CoV-2 infection
27. Primary series and booster COVID-19 vaccine effectiveness in a cohort of healthcare workers in Albania during a BA.1 and BA.2 variant period, January - May 2022
28. US National Institutes of Health Prioritization of SARS-CoV-2 Variants
29. Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters
30. Humoral immune responses remain quantitatively impaired but improve qualitatively in anti-CD20-treated patients with multiple sclerosis after three or four COVID-19 vaccinations
31. Impaired B Cell Recall Memory and Reduced Antibody Avidity but Robust T Cell Response in CVID Patients After COVID-19 Vaccination
32. Endogenous IFITMs boost SARS-Coronavirus 1 and 2 replication while overexpression inhibits infection by relocalizing ACE2
33. Four principles to establish a universal virus taxonomy
34. Functional comparisons of the virus sensor RIG-I from humans, the microbatMyotis daubentonii, and the megabatRousettus aegyptiacus, and their response to SARS-CoV-2 infection
35. Pathogens associated with hospitalization due to acute lower respiratory tract infections in children in rural Ghana: a case–control study
36. Impaired B cell recall memory and reduced antibody avidity but robust T cell response in CVID patients after COVID-19 vaccination
37. Infectivity of an ancient hepatitis B virus cloned after retrieval from archaeological human remains
38. Non-structural genes of novel lemur adenoviruses reveal codivergence of virus and host
39. Corrigendum to ’Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506’ Virus Research (2012) 165/1 [112-117]
40. Hosts and Sources of Endemic Human Coronaviruses
41. Retraction
42. Sensitivity of Detection and Variant Typing of SARS-CoV-2 in European Laboratories
43. Gradual emergence followed by exponential spread of the SARS-CoV-2 Omicron variant in Africa
44. 1358. Establishing Genomic SARS-CoV-2 Surveillance at the National Level: Germany, 2021
45. Analysis of two choir outbreaks acting in concert to characterize long- range transmission risks through SARS-CoV-2, Berlin, Germany, 2020
46. SARS-CoV-2 variant Alpha has a spike-dependent replication advantage over the ancestral B.1 strain in human cells with low ACE2 expression
47. Distinct phenotype of SARS-CoV-2 Omicron BA.1 in human primary cells but no increased host range in cell lines of putative mammalian reservoir species
48. Association of SARS-CoV-2 Seropositivity With Myalgic Encephalomyelitis and/or Chronic Fatigue Syndrome Among Children and Adolescents in Germany
49. Pharmacological inhibition of bromodomain and extra-terminal proteins induces NRF-2-mediated inhibition of SARS-CoV-2 replication and is subject to viral antagonism
50. Importance of external quality assessment for SARS-CoV-2 antigen detection during the COVID-19 pandemic
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.